KRAS and cancer: In cancer, the KRAS gene is typically altered by activating point mutations occurring in hot-spots, mainly in codons 12 and 13 of exon 2 (overall accounting for more than 80% of KRAS mutations) and, less frequently, in codons 59, 61, 117 and 146 [3–7].